White Pine Capital LLC maintained its stake in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,700 shares of the medical device company’s stock at the close of the second quarter. White Pine Capital LLC’s holdings in Cardiovascular Systems were worth $248,000 at the end of the most recent quarter.
Several other hedge funds also recently made changes to their positions in the business. California Public Employees Retirement System grew its stake in shares of Cardiovascular Systems by 0.6% in the 1st quarter. California Public Employees Retirement System now owns 31,900 shares of the medical device company’s stock valued at $902,000 after purchasing an additional 200 shares during the last quarter. Legal & General Group Plc grew its stake in shares of Cardiovascular Systems by 2.9% in the 2nd quarter. Legal & General Group Plc now owns 7,763 shares of the medical device company’s stock valued at $249,000 after purchasing an additional 216 shares during the last quarter. Chicago Equity Partners LLC grew its stake in shares of Cardiovascular Systems by 1.0% in the 1st quarter. Chicago Equity Partners LLC now owns 30,890 shares of the medical device company’s stock valued at $873,000 after purchasing an additional 300 shares during the last quarter. American Century Companies Inc. grew its stake in shares of Cardiovascular Systems by 0.7% in the 2nd quarter. American Century Companies Inc. now owns 81,325 shares of the medical device company’s stock valued at $2,621,000 after purchasing an additional 568 shares during the last quarter. Finally, Stratos Wealth Partners LTD. grew its stake in shares of Cardiovascular Systems by 8.8% in the 2nd quarter. Stratos Wealth Partners LTD. now owns 9,850 shares of the medical device company’s stock valued at $317,000 after purchasing an additional 800 shares during the last quarter. Institutional investors own 74.70% of the company’s stock.
Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) opened at 30.18 on Tuesday. The stock’s market capitalization is $995.67 million. The company has a 50 day moving average price of $30.39 and a 200-day moving average price of $30.08. Cardiovascular Systems, Inc. has a 1-year low of $21.29 and a 1-year high of $33.11.
Cardiovascular Systems (NASDAQ:CSII) last issued its quarterly earnings data on Wednesday, August 2nd. The medical device company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.07. Cardiovascular Systems had a positive return on equity of 0.88% and a negative net margin of 0.87%. The business had revenue of $52.90 million during the quarter, compared to analyst estimates of $51.98 million. During the same period in the prior year, the company posted ($0.15) EPS. The business’s revenue for the quarter was up 9.1% compared to the same quarter last year. On average, equities research analysts forecast that Cardiovascular Systems, Inc. will post $0.01 EPS for the current fiscal year.
In other Cardiovascular Systems news, Director Edward M. Brown sold 20,000 shares of the stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $29.16, for a total transaction of $583,200.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Scott R. Ward sold 5,529 shares of the stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $30.41, for a total value of $168,136.89. Following the transaction, the chief executive officer now directly owns 282,536 shares of the company’s stock, valued at $8,591,919.76. The disclosure for this sale can be found here. Insiders sold a total of 51,065 shares of company stock valued at $1,514,031 over the last three months. Corporate insiders own 3.60% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “White Pine Capital LLC Maintains Position in Cardiovascular Systems, Inc. (CSII)” was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://sportsperspectives.com/2017/09/12/white-pine-capital-llc-maintains-position-in-cardiovascular-systems-inc-csii.html.
Several research analysts have weighed in on CSII shares. Needham & Company LLC reiterated a “buy” rating and issued a $37.00 target price (up from $32.00) on shares of Cardiovascular Systems in a research note on Friday, July 14th. Bank of America Corporation downgraded Cardiovascular Systems from a “neutral” rating to an “underperform” rating in a research note on Wednesday, June 21st. BidaskClub downgraded Cardiovascular Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Finally, Zacks Investment Research downgraded Cardiovascular Systems from a “hold” rating to a “sell” rating in a research note on Friday, August 4th. Three investment analysts have rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating to the company. Cardiovascular Systems has a consensus rating of “Hold” and an average target price of $33.83.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII).
Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.